In the last trading session, 1.48 million shares of the Staar Surgical Co (NASDAQ:STAA) were traded, and its beta was 0.79. Most recently the company’s share price was $17.75, and it changed around $1.28 or 7.77% from the last close, which brings the market valuation of the company to $875.53M. STAA currently trades at a discount to its 52-week high of $52.68, offering almost -196.79% off that amount. The share price’s 52-week low was $13.50, which indicates that the current value has risen by an impressive 23.94% since then.
Staar Surgical Co stock received a consensus recommendation rating of Hold, based on a mean score of 2.69. If we narrow it down even further, the data shows that 1 out of 13 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 9 recommended STAA as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Staar Surgical Co is expected to report earnings per share of -0.58 for the current quarter.
Staar Surgical Co (NASDAQ:STAA) trade information
Instantly STAA has showed a green trend with a performance of 7.77% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 18.43 on recent trading dayincreased the stock’s daily price by 3.69%. The company’s shares are currently down -26.92% year-to-date, but still up 6.99% over the last five days. On the other hand, Staar Surgical Co (NASDAQ:STAA) is -26.62% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $48, which translates to bulls needing to increase their stock price by 63.02% from its current value. Analyst projections state that STAA is forecast to be at a low of $45.03 and a high of $85.
Staar Surgical Co (STAA) estimates and forecasts
The year-over-year growth rate is expected to be -16.93%, down from the previous year.
Consensus estimates provided by 11 financial analysts predict the company will bring in an average of 40.33M in revenue for the current quarter. 11 analysts expect Staar Surgical Co to make 41.1M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 77.36M and 99M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -47.87%. Forecasts for the next quarter put sales growth at -58.49%.
Staar Surgical Co earnings are expected to increase by -530.67% in 2025, but the outlook is positive 20.23% per year for the next five years.
STAA Dividends
Staar Surgical Co’s next quarterly earnings report is expected to be released in April.
BLACKROCK INC., with 15.3123% or 7.49 million shares worth $356.54 million as of 2024-06-30, holds the second largest percentage of outstanding shares.